238 related articles for article (PubMed ID: 36638898)
1. The convergence of pharmacometrics and quantitative systems pharmacology in pharmaceutical research and development.
Joshi A; Ramanujan S; Jin JY
Eur J Pharm Sci; 2023 Mar; 182():106380. PubMed ID: 36638898
[TBL] [Abstract][Full Text] [Related]
2. Two heads are better than one: current landscape of integrating QSP and machine learning : An ISoP QSP SIG white paper by the working group on the integration of quantitative systems pharmacology and machine learning.
Zhang T; Androulakis IP; Bonate P; Cheng L; Helikar T; Parikh J; Rackauckas C; Subramanian K; Cho CR;
J Pharmacokinet Pharmacodyn; 2022 Feb; 49(1):5-18. PubMed ID: 35103884
[TBL] [Abstract][Full Text] [Related]
3. Drug-disease modeling in the pharmaceutical industry - where mechanistic systems pharmacology and statistical pharmacometrics meet.
Helmlinger G; Al-Huniti N; Aksenov S; Peskov K; Hallow KM; Chu L; Boulton D; Eriksson U; Hamrén B; Lambert C; Masson E; Tomkinson H; Stanski D
Eur J Pharm Sci; 2017 Nov; 109S():S39-S46. PubMed ID: 28506868
[TBL] [Abstract][Full Text] [Related]
4. Application of pharmacometrics and quantitative systems pharmacology to cancer therapy: The example of luminal a breast cancer.
Fleisher B; Brown AN; Ait-Oudhia S
Pharmacol Res; 2017 Oct; 124():20-33. PubMed ID: 28735000
[TBL] [Abstract][Full Text] [Related]
5. Review of applications and challenges of quantitative systems pharmacology modeling and machine learning for heart failure.
Cheng L; Qiu Y; Schmidt BJ; Wei GW
J Pharmacokinet Pharmacodyn; 2022 Feb; 49(1):39-50. PubMed ID: 34637069
[TBL] [Abstract][Full Text] [Related]
6. Physiological Indirect Response Model to Omics-Powered Quantitative Systems Pharmacology Model.
Uatay A; Gall L; Irons L; Tewari SG; Zhu XS; Gibbs M; Kimko H
J Pharm Sci; 2024 Jan; 113(1):11-21. PubMed ID: 37898164
[TBL] [Abstract][Full Text] [Related]
7. Recent applications of quantitative systems pharmacology and machine learning models across diseases.
Aghamiri SS; Amin R; Helikar T
J Pharmacokinet Pharmacodyn; 2022 Feb; 49(1):19-37. PubMed ID: 34671863
[TBL] [Abstract][Full Text] [Related]
8. Virtual Populations for Quantitative Systems Pharmacology Models.
Cheng Y; Straube R; Alnaif AE; Huang L; Leil TA; Schmidt BJ
Methods Mol Biol; 2022; 2486():129-179. PubMed ID: 35437722
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Systems Pharmacology for Rare Disease Drug Development.
Bai JP; Wang J; Zhang Y; Wang L; Jiang X
J Pharm Sci; 2023 Sep; 112(9):2313-2320. PubMed ID: 37422281
[TBL] [Abstract][Full Text] [Related]
10. From Cold to Hot: Changing Perceptions and Future Opportunities for Quantitative Systems Pharmacology Modeling in Cancer Immunotherapy.
Lemaire V; Bassen D; Reed M; Song R; Khalili S; Lien YTK; Huang L; Singh AP; Stamatelos S; Bottino D; Hua F
Clin Pharmacol Ther; 2023 May; 113(5):963-972. PubMed ID: 36282521
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Systems Pharmacology and Machine Learning: A Match Made in Heaven or Hell?
Tindall MJ; Cucurull-Sanchez L; Mistry H; Yates JWT
J Pharmacol Exp Ther; 2023 Oct; 387(1):92-99. PubMed ID: 37652709
[TBL] [Abstract][Full Text] [Related]
12. A framework for simplification of quantitative systems pharmacology models in clinical pharmacology.
Derbalah A; Al-Sallami H; Hasegawa C; Gulati A; Duffull SB
Br J Clin Pharmacol; 2022 Feb; 88(4):1430-1440. PubMed ID: 32621550
[TBL] [Abstract][Full Text] [Related]
13. Pharmacometrics meets statistics-A synergy for modern drug development.
Ryeznik Y; Sverdlov O; Svensson EM; Montepiedra G; Hooker AC; Wong WK
CPT Pharmacometrics Syst Pharmacol; 2021 Oct; 10(10):1134-1149. PubMed ID: 34318621
[TBL] [Abstract][Full Text] [Related]
14. Pharmacometrics and Systems Pharmacology 2030.
Mentré F; Friberg LE; Duffull S; French J; Lauffenburger DA; Li L; Mager DE; Sinha V; Sobie E; Zhao P
Clin Pharmacol Ther; 2020 Jan; 107(1):76-78. PubMed ID: 31758700
[TBL] [Abstract][Full Text] [Related]
15. Educational Needs for Quantitative Systems Pharmacology Scientists.
Gallo JM
Methods Mol Biol; 2022; 2486():335-343. PubMed ID: 35437730
[TBL] [Abstract][Full Text] [Related]
16. Towards Quantitative Systems Pharmacology Models of Chemotherapy-Induced Neutropenia.
Craig M
CPT Pharmacometrics Syst Pharmacol; 2017 May; 6(5):293-304. PubMed ID: 28418603
[TBL] [Abstract][Full Text] [Related]
17. Applications of Quantitative System Pharmacology Modeling to Model-Informed Drug Development.
Zhu AZX; Rogge M
Methods Mol Biol; 2022; 2486():71-86. PubMed ID: 35437719
[TBL] [Abstract][Full Text] [Related]
18. Machine learning-guided, big data-enabled, biomarker-based systems pharmacology: modeling the stochasticity of natural history and disease progression.
McComb M; Blair RH; Lysy M; Ramanathan M
J Pharmacokinet Pharmacodyn; 2022 Feb; 49(1):65-79. PubMed ID: 34611796
[TBL] [Abstract][Full Text] [Related]
19. Creating a Roadmap to Quantitative Systems Pharmacology-Informed Rare Disease Drug Development: A Workshop Report.
Bai JPF; Stinchcomb AL; Wang J; Earp J; Stern S; Schuck RN
Clin Pharmacol Ther; 2024 Feb; 115(2):201-205. PubMed ID: 37984065
[TBL] [Abstract][Full Text] [Related]
20. Advancing pharmacometrics and systems pharmacology.
Waldman SA; Terzic A
Clin Pharmacol Ther; 2012 Nov; 92(5):535-7. PubMed ID: 23085873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
